About 2 000 South African children will take part in a global Covid-19 vaccine trial, with the first child to be inoculated in Pretoria today.

Published on

10 September 2021

South Africa is one of five countries to participate in Sinovac’s CoronaVac trial. The global trial will enrol 14 000 children, aged between 6 months and 17 years. The COO of Numolux, acting on behalf of Sinovac, Anton Arendse, says the CoronaVac vaccine is safe and has been approved for use by SAHPRA. Phase 1 and 2 trials in China have shown CoronaVac is well-tolerated in children and adolescents aged 3-17 years and induces a strong immune response. SAHPRA and the World Health Organisation have approved the global trial.

Merentia Van Der Vent

Merentia joined the media world in 1996 and in 2001, she took her first steps in the broadcasting world. In her free time, she likes to go on adventures in the city. She also likes to learn new dances, not that she is any good at that.

Latest articles

The Western Cape Department of Health says more than 90% of covid-19 patients, currently in hospitals, are unvaccinated.

The country has recorded 6 270 new coronavirus cases, over the latest 24-hour monitoring period.

About 2 000 South African children will take part in a global Covid-19 vaccine trial, with the first child to be inoculated in Pretoria today.

Latest articles

Bodies of three, including baby girl, stolen from funeral home

Alleged assault at SA’s Antarctica base grabs global headlines

NSRI: Body of man washed found at sea in Plettenberg Bay

Win R5000 with Satiskin!

Massive bridge beams moved to Manenberg

A benefit evening will be held, celebrating the legacy of The Masque Theatre

Cape Town’s public transport system has gone greener

Click here for T&cs